GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (SHSE:600671) » Definitions » Net Income Including Noncontrolling Interests

Hangzhou TianMuShan Pharmaceutical Enterprise Co (SHSE:600671) Net Income Including Noncontrolling Interests : ¥-66.3 Mil (TTM As of Sep. 2023)


View and export this data going back to 1993. Start your Free Trial

What is Hangzhou TianMuShan Pharmaceutical Enterprise Co Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Hangzhou TianMuShan Pharmaceutical Enterprise Co's Net Income Including Noncontrolling Interests for the three months ended in Sep. 2023 was ¥-3.9 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Sep. 2023 was ¥-66.3 Mil.

Hangzhou TianMuShan Pharmaceutical Enterprise Co Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Hangzhou TianMuShan Pharmaceutical Enterprise Co's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou TianMuShan Pharmaceutical Enterprise Co Net Income Including Noncontrolling Interests Chart

Hangzhou TianMuShan Pharmaceutical Enterprise Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.66 52.06 -51.55 -32.78 -73.21

Hangzhou TianMuShan Pharmaceutical Enterprise Co Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.08 -38.74 -9.97 -13.67 -3.88

Hangzhou TianMuShan Pharmaceutical Enterprise Co Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-66.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hangzhou TianMuShan Pharmaceutical Enterprise Co Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Hangzhou TianMuShan Pharmaceutical Enterprise Co's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Hangzhou TianMuShan Pharmaceutical Enterprise Co (SHSE:600671) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (SHSE:600671) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
SZSE:000908 SZSE:000952 SZSE:001367 SZSE:000705 SZSE:301281 SZSE:300006 SZSE:002198 SHSE:600613 SHSE:600666 SZSE:301507 LLY JNJ MRK ABBV LSE:AZN XSWX:ROG XSWX:NOVN PFE AMGN XPAR:SAN
Traded in Other Exchanges
N/A
Address
No.18 Shangyang Road, Jinnan Street, Lin'an District, Zhejiang Province, Hangzhou, CHN, 311300
Website
http://www.hztmyy.com
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd is engaged in producing proprietary Chinese medicines, biopharmaceuticals, healthy foods, medical equipment, and other medicines in China. The company is also engaged in medical device production and sales, cosmetics production, sales, production and sales of sanitary products.

Hangzhou TianMuShan Pharmaceutical Enterprise Co (SHSE:600671) Headlines

No Headlines